Rapid Nutrition Recognised by Australian Government for product Innovation and Export Success
London, UnitedKingdom – 19th May 2022 - Rapid Nutrition PLC (Euronext Growth: ALRPD, OTCQB: RPNRF) is pleased to announce that its Australian subsidiary has secured a twelve-month funding agreement from the Australian Government to further expand its international presence.
The Australian government recently announced that it will provide financial grants to support to well-established Australian businesses expanding export promotional activities and those that are making a strategic shift in their marketing activities with continued product innovation in order to access new markets or market segments driven by key business goals.
“We are honored and humbled to be recognised again by the Australian government and to be one of the privileged few companies to be selected to take part in this program to further accelerate our global expansion activities,” said Rapid Nutrition CEO Simon St. Ledger. “This vote of confidence truly reinforces that we are moving full steam ahead in the right direction and it also allows us the ability to aggressively expand into key new markets, knowing we have the financial backing to continue our goal of becoming a market leader within our industry.”
The timing couldn’t be better as Rapid Nutrition recently announced notable product expansion and innovation via its flagship brand SystemLS. In addition, it is now in the final stages of commercialising its patented herbal anti-viral to boost immunity as the national government continues to support leading Australian exporters who continue to innovate and diversify their product offering.
In 2021, Rapid Nutrition secured distribution deals in the Middle East, Egypt, Africa and South Korea in addition to significant ecommerce gains. The company continues to focus on key markets including the UK, Europe, Australia, the United States and China.
About Rapid Nutrition
Dedicated to the development and distribution of premium, science-based health and wellness brands across the globe, Rapid Nutrition shares a wealth of award-winning products with consumers who are passionate about innovations that are “made by nature, refined by science.” Rapid Nutrition’s first-class scientific team matches the experience of its management team to keep both the company and consumers on top of the latest industry trends and developments, while aligning with industry leaders worldwide to deliver effective supplements and solutions. Rapid Nutrition aims to be the supplier of choice globally by offering premium brands with the highest-quality ingredients to deliver maximum results.
For more information, please visit http://rnplc.com
Investor Relations Contact:
Disclaimer
This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and or otherwise that involve risks, uncertainties and assumptions that could cause Rapid Nutrition PLCs actual results and experience to differ materially from anticipated results and expectations expressed in these forward-looking statements. Rapid Nutrition PLC has in some cases identified forward-looking statements by using words such as "anticipates," "believes," "hopes," "estimates," "looks," "expects," "plans," "intends," "goal," "potential," "may," "suggest," and similar expressions. Rapid Nutrition PLC undertakes no obligation to release publicly the results of any revisions to any such forward-looking statements that may be made to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events, except as required by applicable law or regulation.
This media information does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. This information does not constitute an offering prospectus within the meaning within the meaning of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 of June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71 or a listing prospectus within the meaning of the listing rules of the Euronext Exchange or OTC Markets. The media release is in accordance with International Reporting Standard: Rule 12g3-2(b) under the Securities Exchange Act ('Rule 12g3-2(b)') permits non-U.S. companies with securities listed primarily on a Qualified Foreign Exchange to make publicly available to U.S investors in English the same information that is made publicly available in their home countries as an alternative to SEC reporting Exchange Act Rule 12g3-2(b).